Skip to content

LifeMD, Inc. LFMD Debt issuance costs and discount amortization

Debt issuance costs and discount amortization at other companies

PTH
Pelthos Therapeutics Inc.PTHS
$195K+107%

Other financials

Income statement

See full
Revenue$50.2M-1.4%
Gross profit$44.2M+3.5%
Operating income-$8.9M-656%
Net income-$8.9M-4,728%
EPS (diluted)-$0.20-900%

Balance sheet

See full
Cash & equivalents$34.5M+7.9%
Total debt$6.2M-76.9%
Total equity$15.0M+746%
Total assets$70.1M-4.7%

Cash flow

See full
Operating cash flow$444.6K-85.5%
CapEx$105.2K-10.5%
Free cash flow$339.4K-88.5%

Valuation

See full
Market cap$235.53M-61.7%
Enterprise value$207.22M-66.2%
P/E41.6×
P/S1.3×-2.3×

Profitability

See full
Gross margin86.1%+0.9pp
Operating margin-9.8%-0.9pp
Net margin3.1%+1.8pp
FCF margin10.4%+1.7pp

Returns & leverage

See full
Return on equity-393.6%
Debt / equity0.4×
Current ratio+0.2×

Where this comes from

Reported directly by LifeMD, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfDebtDiscountPremium.

The official record: LifeMD, Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeMD, Inc.'s debt issuance costs and discount amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeMD, Inc.'s debt issuance costs and discount amortization?
LifeMD, Inc. (LFMD) reported debt issuance costs and discount amortization of $0 in Q4 2025.
How has LifeMD, Inc.'s debt issuance costs and discount amortization changed year-over-year?
LifeMD, Inc.'s debt issuance costs and discount amortization decreased by 100.0% year-over-year, from $100.44K to $0.
What is the long-term trend for LifeMD, Inc.'s debt issuance costs and discount amortization?
Over 3 years (2021 to 2025), LifeMD, Inc.'s debt issuance costs and discount amortization has grown at a -52.4% compound annual growth rate (CAGR), from $2.17M to $234.37K.
What does debt issuance costs and discount amortization mean?
Reflects the non-cash periodic expense recognized to amortize debt issuance costs or original issue discounts over the life of a debt instrument. This adjustment reconciles net income to operating cash flow by accounting for the effective interest expense incurred beyond actual cash interest payments.